Pituitary Targeting for Intractable Cancer Pain: A Systematic Review and Current Recommendations
Stereotactic and Functional Neurosurgery · 2025
DOI: 10.1159/000547889 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Stereotactic and Functional Neurosurgery, 2025. Verfasst von Anne Balossier und 2 weiteren Autor:innen. Beteiligte Einrichtung: AP-HM, Timone Hospital, Functional and Stereotactic Neurosurgery, Marseille, France, anne.balossier@ap-hm.fr. Hauptthemen laut MEDLINE: Cancer Pain, Pain Management, Intractable Pain, Pituitary Gland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background: Most patients suffering from cancer will face pain during the course of their disease. Pain is a source of major discomfort and alteration of quality of life. Pituitary targeting, initially reported as hypophysectomy, was first proposed to control endocrine cancer. Although this technique did not improve the overall tumoral control, it rapidly showed an interesting effect on cancer pain related to bone metastases. Due to the complications, this technique gradually decreased and finally fell into disuse. Recently, some authors have shown a regained interest in pituitary targeting using a radiosurgical procedure, in order to limit surgical complications, with interesting results. We performed a systematic review of the literature and meta-analysis with the aim of evaluating the outcome and complications of pituitary targeting and determining its current place in the management of cancer pain. Summary: Twenty-four studies were included in this systematic review (700 patients). Nineteen studies reported the results of surgical and 5 studies of stereotactic radiosurgical pituitary targeting. Pain relief was reported in 82.2% and 93.5% for surgery and radiosurgery, respectively. On the long-term, pain relief was maintained in 80.2% and 88.6% for surgery and radiosurgery, respectively. Complications varied among treatment modalities, with diabetes insipidus being the most common complication. Key Messages: Pituitary targeting remains an attractive option for refractory cancer-related pain after failure of traditional therapies. Radiosurgery is a promising treatment modality due to its high success rate and reduced risk of complications and should be recommended over surgery whenever possible. Pain relief is presumably related to a neuromodulation mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AP-HM, Timone Hospital, Functional and Stereotactic Neurosurgery, Marseille, France, anne.balossier@ap-hm.fr.
- Aix Marseille University, INSERM, Institute Neurosciences des Sysèmes, Marseille, France, anne.balossier@ap-hm.fr.
- AP-HM, Timone Hospital, Functional and Stereotactic Neurosurgery, Marseille, France.
- Aix Marseille University, INSERM, Institute Neurosciences des Sysèmes, Marseille, France.
Zitieren
APA
Balossier, A., Soussi, G., & Régis, J. (2025). Pituitary Targeting for Intractable Cancer Pain: A Systematic Review and Current Recommendations. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/000547889
Vancouver
Balossier A, Soussi G, Régis J. Pituitary Targeting for Intractable Cancer Pain: A Systematic Review and Current Recommendations. Stereotactic and Functional Neurosurgery. 2025. doi:10.1159/000547889
BibTeX
@article{Balossier2025,
author = {Balossier, Anne and Soussi, Ghassen and Régis, Jean},
title = {Pituitary Targeting for Intractable Cancer Pain: A Systematic Review and Current Recommendations},
journal = {Stereotactic and Functional Neurosurgery},
year = {2025},
doi = {10.1159/000547889}
}
EUVIMED